The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
The Rationale for Prostaglandin E1 in Erectile Failure: A Survey of Worldwide Experience
Abstract
PURPOSE: Prostaglandin E1 (PGE1, alprostadil) is used worldwide for self-injection therapy in erectile failure and was recently officially approved for this purpose in the United States and most European countries. Therefore a comprehensive overview on biochemistry, pharmacology and therapeutic results of PGE1 is provided. MATERIALS AND METHODS: The relevant literature on PGE1 was reviewed along with personal experience with 4,577 patients during a 7-year period. PGE1 was compared to other vasoactive drugs, such as papaverine, the mixture of papaverine and phentolamine or linsidomine alone. RESULTS: In Europe PGE1 was officially approved for the therapy of peripheral arterial occlusive disease of the lower limbs in 1984. The drug has direct relaxing effects on smooth muscle cells of vessels and cavernous bodies, shows inhibitory effects on platelet aggregation, on low-density lipoprotein entry into the vascular wall and on presynaptic noradrenaline release and, therefore, it prevents the progress of atherosclerosis. In erectile failure PGE1 shows a response rate of more than 70% and, compared to papaverine with phentolamine, a considerably lower risk of priapism (0.35% versus 6%, respectively) as well as of local fibrotic complications. Except for rare cases of blood pressure decrease, no systemic side effects were observed after intracavernous injection of PGE1. CONCLUSIONS: For self-injection therapy, PGE1 presently represents the most efficacious and safest drug. Ongoing trials with topical and especially intraurethral PGE1 are promising and may offer less invasive therapies in the near future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new view of prostaglandin E regulation of the immune response
Phipps, R. P., Stein, S. H., & Roper, R. L. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90064-z · Cited by 523
Intracavernous Injection of Papaverine as a Diagnostic and Therapeutic Method in Erectile Failure
Virag, R., Frydman, D., Legman, M., & Virag, H. (1984) · Angiology · doi:10.1177/000331978403500203 · Cited by 307
Prostaglandins and Related Factors
Bergström, S., Ryhage, R., Samuelsson, B., & Sjövall, J. (1963) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)75307-1 · Cited by 289
Biochemical Studies of Human Semen. II. The Action of Semen on the Human Uterus.
Kurzrok, R., & Lieb, C. C. (1930) · Experimental Biology and Medicine · doi:10.3181/00379727-28-5265 · Cited by 288
ALPHA-FETOPROTEIN IN ANTENATAL DIAGNOSIS
Seppälä, M., & Ruoslahti, E. (1973) · The Lancet · doi:10.1016/s0140-6736(73)90232-8 · Cited by 263
Metabolism of prostaglandins A1 and E1 in man.
Golub, M., Zia, P., Matsuno, M., & Horton, R. (1975) · Journal of Clinical Investigation · doi:10.1172/jci108221 · Cited by 194
Intracavernous Injection Therapy: Analysis of Results and Complications
Lakin, M. M., Montague, D. K., Medendorp, S. V., Tesar, L., & Schover, L. R. (1990) · Journal of Urology · doi:10.1016/s0022-5347(17)40208-4 · Cited by 171
Intracavernous Injection of Prostaglandin E1 in Impotent Men
Stackl, W., Hasun, R., & Marberger, M. (1988) · Journal of Urology · doi:10.1016/s0022-5347(17)41488-1 · Cited by 170
Hedlund, H., & Andersson, K.-E. (1985) · Journal of Urology · doi:10.1016/s0022-5347(17)47704-4 · Cited by 168
Regulation of Adrenergic Activity in Penile Corpus Cavernosum
de Tejada, I. S., Kim, N. N., Lagan, I., Krane, R. J., & Goldstein, I. (1989) · The Journal of Urology · doi:10.1016/s0022-5347(17)39009-2 · Cited by 155
Cited by
Lue, T. F. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006153422407 · Cited by 1,252
Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation
Hatzimouratidis, K., Amar, E., Eardley, I., Giuliano, F., Hatzichristou, D., Montorsi, F., Vardi, Y., & Wespes, E. (2010) · European Urology · doi:10.1016/j.eururo.2010.02.020 · Cited by 1,223
Priapism: Pathogenesis, Epidemiology, and Management
Broderick, G. A., Kadioglu, A., Bivalacqua, T. J., Ghanem, H., Nehra, A., & Shamloul, R. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2009.01625.x · Cited by 400
Health-related quality of life in men with erectile dysfunction
Litwin, M. S., Nied, R. J., & Dhanani, N. (1998) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.1998.00050.x · Cited by 301
Kandeel, F. R., Koussa, V. K. T., & Swerdloff, R. S. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.3.0430 · Cited by 270
Metadata
- Authors
- Porst, H.
- Venue
- Journal of Urology
- Published
- 1996-03
- Volume
- 155
- Issue
- 3
- Pages
- 802-815
- ISSN
- 0022-5347 (ISSN-L)
- 1527-3792
- OpenAlex
- W2133927893
- Cited by
- 316
- References
- 40
- FWCI
- 16.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Rationale for Prostaglandin E1 in Erectile Failure: A Survey of Worldwide Experience. https://app.cochat.ai/papers/10.1016/s0022-5347(01)66315-8
- The paper
- Porst, H. (1996). The Rationale for Prostaglandin E1 in Erectile Failure: A Survey of Worldwide Experience. Journal of Urology. https://doi.org/10.1016/s0022-5347(01)66315-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.